The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

The global microarray market size was valued at $3.9 billion in 2021, and is projected to reach $8.4 billion by 2031, growing at a CAGR of 7.8% from 2022 to 2031. Microarray is a technology in which a ...

Microarray helps in analyzing large amount of samples which have either been recorded previously or new samples; it even helps to test the incidence of a particular marker in tumors. Till recently, ...

The Microarray Market comprises advanced bioanalytical tools designed to simultaneously analyze large sets of biological data, including gene expression, protein interactions, and DNA sequencing.

Microarray Technology evolved from the initial report in the mid 1970s that labeled nucleic acids could be used to monitor the expression of nucleic acid molecules attached to a solid support occurred ...

DNA microarray technology permits simultaneous analysis of thousands of DNA sequences for genomic research and diagnostics applications. Microarray technology represents the most recent and exciting ...

More than 30% of the world population suffers from allergy. Allergic individuals are characterized by the production of immunoglobulin E (IgE) antibodies against innocuous environmental allergens.

Denervation induces skeletal muscle atrophy, accompanied by complex biochemical and physiological changes, with potentially devastating outcomes even an increased mortality. Currently, however, there ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by ...